Greenwich LifeSciences, Inc. (GLSI) research

Greenwich LifeSciences, Inc.

Sector: Healthcare
Industry: Biotechnology
Last price: $16.98
As of: 2026-10-02

Greenwich LifeSciences, Inc. (GLSI): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-08-11.

As of 2026-08-29, the latest of: this ticker's 13F holdings load, its latest SEC filing date, and its latest signal other than 13F-derived signals. Source: SEC EDGAR filings for GLSI. Method and limitations.

COMPANY DOSSIER

See the full GLSI dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for GLSI on one page. Preview it with sample data, then open it live with a free account.

Preview the GLSI dossier

Active signals for GLSI

mediumEARNINGS_BEAT2026-08-29
Q2-2026: Beat consensus by 19.8%, EPS $-0.27 vs $-0.3366 estimate
All 2026-08-29 signals →
mediumEARNINGS_MISS2026-06-15
Q4-2025: Missed consensus by 77.7% - EPS $-0.58 vs $-0.3264 estimate
All 2026-06-15 signals →
mediumEARNINGS_MISS2026-06-15
Q1-2026: Missed consensus by 15.9% - EPS $-0.39 vs $-0.3366 estimate
All 2026-06-15 signals →
mediumEARNINGS_MISS2026-05-29
Q4-2024: Missed consensus by 184.8% - EPS $-0.61 vs $-0.2142 estimate
All 2026-05-29 signals →
mediumEARNINGS_MISS2026-05-29
Q2-2025: Missed consensus by 22.5% - EPS $-0.3 vs $-0.2448 estimate
All 2026-05-29 signals →

FREE, NO ACCOUNT

Every signal on GLSI, as it fires

New filings, 13F moves and cross asset signals on GLSI land in the record first.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.

Recent SEC filings, GLSI

10-Q2026-08-11
SEC EDGAR ↗
10-Q2026-06-04
SEC EDGAR ↗
10-K2026-06-01
SEC EDGAR ↗
8-K2025-12-18
SEC EDGAR ↗
10-Q2025-11-14
SEC EDGAR ↗
10-Q2025-08-14
SEC EDGAR ↗
8-K2025-07-24
SEC EDGAR ↗
10-Q2025-05-20
SEC EDGAR ↗
10-K2025-04-15
SEC EDGAR ↗
8-K2024-12-19
SEC EDGAR ↗

GLSI against its peers

GLSI's return on equity of -5480.5% ranks in the 2nd percentile of 20 Biotechnology sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-05-31.

Metric	GLSI	Peer median	Percentile	n
Revenue FY	n/a	31.4M	n/a	17
Operating margin	n/a	-340.4%	n/a	15
Net margin	n/a	-263.6%	n/a	16
Return on equity	-5480.5%	-38.2%	2	20

Peers (23): IMRX, STRO, ACIU, SABS, CYDY, QTTB, UPB, NWBO, ANIK, FATE, IKT, IFRX, XFOR, EYPT, CAMP, PALI, RCKT, ABEO, IPSC, VNDA, BCYC, IVVD, LXEO. Left out: VCRE (no annual filing), CUVL (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-05-31. Every figure is one full fiscal year read from one annual filing (GLSI: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

See more GLSI signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to GLSIand get the insider, 13F, options, and confluence read in one view.